GSK Turkey made a new reconstruction in departments of communication and trade excellence
One of the world’s leading research-based pharmaceutical and healthcare companies, GlaxoSmithKline operates globally with business units focused on pharmaceuticals, vaccines and consumer healthcare products. With reorganisation in GSK Turkey communication department, Communications Department called as “Communication and Patient Relations Department”. Tugba Çamlı Cantürk, Communications Manager was appointed to Head of Communications and Patient Relations at GSK Turkey. Department of Commerce Excellence expanded as Department of Business Excellence. Bilgen Tan, Trade Excellence Manager, was appointed to Business Excellence Manager. GSK Turkey made a new reconstruction in departments of communication and trade excellence. Pharmaceuticals: Pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. GSK’s portfolio is made up of both patent-protected and off patent medicines. Vaccines: GSK’s Vaccines business is one of the largest in the world, producing paediatric and adult vaccines against a range of infectious diseases. In 2014, GSK distributed more than 800 million doses to 170 countries, of which over 80% were supplied to developing countries. Consumer Healthcare: GSK develops and markets a range of consumer healthcare products based on scientific innovation. GSK has brands in four main categories: Wellness, Oral Health, Skin Health and Nutrition. These include a number of well-known brands such as Sensodyne, Panadol and Horlicks.